Who We Are
Our goal is to accelerate and improve the likelihood of innovations reaching the global market to enhance patient lives.
Our partnership-enabled business model focuses on forging strategic collaborations with and licensing patented technologies to leading medical device companies to drive successful global commercialization of products we help develop. Using this approach, we focus on advancing promising therapeutic solutions, such as Virtue SAB and BackBeat CNT, through late-stage clinical research and regulatory approvals, while our partners focus on leveraging their commercial expertise and existing infrastructure to bring our products to global markets quickly and efficiently.
Virtue® SAB is not approved for commercial use in the US
BackBeat CNT™ is not approved for commercial use in the US
© 2022 Orchestra BioMed Inc. Virtue®, BackBeat CNT™ FreeHold Duo®, FreeHold Trio® and Orchestra BioMed™ are trademarks of Orchestra BioMed.
All other trademarks are trademarks of their respective owners.
SM-0020 Rev 01